Macular degeneration poses a significant threat to central vision, affecting millions in crucial daily activities such as reading and driving.
Understanding Macular Degeneration: Key Facts
In wet age-related macular degeneration (AMD), the cause of the condition lies in the development of new blood vessels driven by the vascular endothelial growth factor (VEGF). As the disease progresses, patients often experience symptoms like blurred vision and visual distortions.
The Role of Macular Injections in Treatment
Macular injections have emerged as a pivotal treatment for wet AMD. With medications like brolucizumab (Beovu®) and aflibercept (Eylea®), these injections strive to stabilize or potentially improve eyesight, preserving essential activities. The cornerstone of these injections is their ability to effectively block VEGF proteins, thereby halting the abnormal growth of blood vessels in the retina.